Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-ß and p38/ERK MAPK signalling.
Biomed Pharmacother
; 168: 115817, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37925934
Full text:
1
Database:
MEDLINE
Main subject:
Endometrial Neoplasms
/
Diabetes Mellitus, Type 2
/
Metformin
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Biomed Pharmacother
Year:
2023
Type:
Article
Affiliation country:
Spain